High-dose treatments may give faster results, while lower doses are gentler and safer for maintenance
Karthik Achari, founder and CEO of PepMD, said that the strongest argument against GLP-1s being PEDs is the fact that the drugs would likely harm athletic performance more than they would help
They slow gastric emptying, improve insulin sensitivity, reduce hepatic glucose production, and appear to have direct cardiovascular benefits independent of weight loss
Holguin, F
Mounjaro and Wegovy work through overlapping mechanisms, so the transition between them is generally well tolerated
After three years of earnings decline, Motilal Oswal Financial Services expects a CAGR of 14%, 20%, and 27% in revenue, EBITDA, and net profit over FY25-27